Literature DB >> 15912266

Cell-cycle-dependent efficacy of photodynamic therapy with ATX-S10(Na).

Munetaka Sano1, Takahisa Furuta, Kenichiro Takahira, Masayoshi Kajimura, Hiroyuki Hanai, Eiji Kohno, Toru Hirano, Akira Hishida.   

Abstract

Photodynamic therapy (PDT) is a useful strategy for treating various cancers. Details of the mechanisms of PDT have not been made clear yet. We intended to study the efficacy of PDT in relation to the cell cycle. HeLa S3 cells were synchronized by the thymidine block method. Cells in different cell cycle phases after release were treated with the water-soluble photosensitizer, ATX-S10(Na). The cellular viability after PDT was determined by the MTT assay. Intracellular levels of ATX-S10(Na) in different cell cycle phases were also determined. We found that cells in the S and G(2)/M phases were hypersensitive to PDT with ATX-S10(Na) in comparison with those in the G(1) phase, and that cellular levels of ATX-S10(Na) were increased in cells in the S and G(2)/M phases compared to those in the G(1) phase. We conclude that cellular ATX-S10(Na) levels differ among the different cell cycle phases, which is associated with the cell-cycle-dependent efficacy of PDT with ATX-S10(Na).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15912266     DOI: 10.1007/s10103-005-0337-y

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  23 in total

Review 1.  The history of photodetection and photodynamic therapy.

Authors:  R Ackroyd; C Kelty; N Brown; M Reed
Journal:  Photochem Photobiol       Date:  2001-11       Impact factor: 3.421

2.  Cell cycle dependency of porphyrin uptake in a glioma cell line.

Authors:  Y Shibata; A Matsumura; F Yoshida; T Yamamoto; K Nakai; T Nose; I Sakata; S Nakajima
Journal:  Cancer Lett       Date:  1998-07-03       Impact factor: 8.679

3.  Hemopexin as a carrier protein of tumor-localizing Ga-metalloporphyrin-ATN-2.

Authors:  S Nakajima; T Moriyama; H Hayashi; I Sakata; Y Nakae; T Takemura
Journal:  Cancer Lett       Date:  2000-02-28       Impact factor: 8.679

4.  Use of a tetrazolium based colorimetric assay in assessing photoradiation therapy in vitro.

Authors:  A P McHale; L McHale
Journal:  Cancer Lett       Date:  1988-08-30       Impact factor: 8.679

5.  Enhanced antitumour effect of photodynamic therapy by microtubule inhibitors.

Authors:  L W Ma; K Berg; H E Danielsen; O Kaalhus; V Iani; J Moan
Journal:  Cancer Lett       Date:  1996-12-03       Impact factor: 8.679

6.  Effect of mitomycin C on the uptake of photofrin II in a human colon adenocarcinoma cell line.

Authors:  L W Ma; J Moan; H B Steen; K Berg; Q Peng
Journal:  Cancer Lett       Date:  1992-06-15       Impact factor: 8.679

7.  Cytotoxicity and cytokinetic effects of mitomycin C and/or photochemotherapy in a human colon adenocarcinoma cell line.

Authors:  L W Ma; H B Steen; J Moan; K Berg; Q Peng; H Saether; C Rimington
Journal:  Int J Biochem       Date:  1992-11

8.  Mitotic inhibition by phenylporphines and tetrasulfonated aluminium phthalocyanine in combination with light.

Authors:  K Berg; J Moan
Journal:  Photochem Photobiol       Date:  1992-09       Impact factor: 3.421

9.  A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group.

Authors:  K Furuse; M Fukuoka; H Kato; T Horai; K Kubota; N Kodama; Y Kusunoki; N Takifuji; T Okunaka; C Konaka
Journal:  J Clin Oncol       Date:  1993-10       Impact factor: 44.544

10.  Anti-tumour activity of photodynamic therapy in combination with mitomycin C in nude mice with human colon adenocarcinoma.

Authors:  L W Ma; J Moan; H B Steen; V Iani
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.